Viewing Study NCT01627561


Ignite Creation Date: 2025-12-24 @ 12:21 PM
Ignite Modification Date: 2026-01-19 @ 5:24 PM
Study NCT ID: NCT01627561
Status: COMPLETED
Last Update Posted: 2020-04-10
First Post: 2012-06-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old
Sponsor: GlaxoSmithKline
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 115887
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators